Zhangyu Lin

Zhangyu Lin

Auto-generated profile, based on publicly available information

Zhangyu Lin

Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No 167 North Lishi Road, Xicheng District, Beijing, 100037, China, 86 88398866

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
CSChenxi Song
Chenxi Song
ZQZheng Qiao
Zheng Qiao
JCJiaxi Cheng
Jiaxi Cheng
YZYuze Zhang
Yuze Zhang
WLWeida Liu
Weida Liu
KDKe-Fei Dou
Ke-Fei Dou
Background: The optimal definition and risk stratification approach to identify high‐risk patients with prediabetes and stable coronary heart disease has not been well studied to date. The objective of the current study is to compare the prognostic value of different definitions of prediabetes, and to explore the role of “very‐high‐risk” (VHR) criteria according to the 2018 American Heart Association/American College of Cardiology cholesterol guideline in the risk stratification of patients with prediabetes and stable coronary heart disease. Methods and Results: This prospective large‐cohort study enrolled a total of 7930 patients with stable coronary heart disease. Prediabetes was defined according to various guidelines and further classified on the basis of the VHR criteria according to the 2018 American Heart Association/American College of Cardiology guideline. The primary end point was major adverse cardiovascular events (MACEs), which was defined as the composite end point of cardiac death, nonfatal acute myocardial infarction, and stroke. During a median of 3 years’ follow‐up, a total of 256 MACEs occurred. Prediabetes defined according to the World Health Organization/International Expert Committee criteria was associated with significant increased MACE risk compared with normoglycemia (adjusted hazard ratio [HR], 1.484 [95% CI, 1.139–1.935]; P =0.0035). The VHR group was associated with increased MACE risk compared with the non‐VHR group (adjusted HR, 1.783 [95% CI, 1.344–2.366], P <0.0001). The VHR criteria played an important role in risk stratification, and prediabetes combined with VHR criteria was associated with higher MACE risk regardless of the prediabetes definition. Conclusions: Our findings suggested the potential use of the World Health Organization/International Expert Committee definition and VHR criteria in risk stratification of patients with prediabetes and stable coronary heart disease.

16 July 2026 in Journal of Medical Internet Research
Verified
Journal Article
Open access
ZYZixiang Ye
Zixiang Ye
EXEnmin Xie
Enmin Xie
ZLZhangyu Lin
Zhangyu Lin
CSChenxi Song
Chenxi Song
RZRui Zhang
Rui Zhang
KDKe-Fei Dou
Ke-Fei Dou
Background: Patients with coronary artery calcification exhibit notable sex differences in clinical presentation, particularly concerning the role of cardiovascular-kidney-metabolic (CKM) risk factors and their impact on prognoses. However, the precise nature of these sex-specific differences remains incompletely understood. Objective: This study aimed to investigate sex disparities in CKM risk factors among patients with moderate-to-severe coronary artery calcification (MSCAC) and elucidate their association with adverse clinical outcomes. Methods: A total of 2418 patients with MSCAC undergoing their first percutaneous coronary intervention were included. Hazard ratios (HRs) were computed to evaluate sex differences in the prognostic significance of various CKM risk factors, including chronic kidney disease (CKD), diabetes mellitus (DM), obesity, hypertension, and hypertriglyceridemia. Four machine learning models—logistic regression, extreme gradient boosting (XGBoost), random forest, and support vector machine—were constructed to predict adverse events. The best-performing model was interpreted using Shapley additive explanations (SHAP) values to identify the relative importance of CKM risk factors and clarify potential sex disparities. Major adverse cardiovascular events (MACEs) were defined as all-cause mortality, nonfatal myocardial infarction, and unplanned repeat revascularization. Results: Among the participants, 86.9% (2101/2418) had ≥1 CKM risk factor, while 3.1% (74/2418) had ≥4 risk factors. CKD was independently associated with the occurrence of MACEs in both female patients (HR 2.65, 95% CI 1.50-4.69) and male patients (HR 1.53, 95% CI 1.02-2.60). Notably, the association was stronger in female patients, with a female-to-male multivariate-adjusted HR ratio for CKD of 1.68 (95% CI 1.04-2.97). DM was also associated with MACEs in both sexes, with adjusted HRs of 1.20 (95% CI 1.02-1.92) in female patients and 1.59 (95% CI 1.19-2.12) in male patients. Among the models evaluated, XGBoost demonstrated the highest predictive performance in the test set (area under the curve 0.92; average precision 0.92; F1-score=0.86). XGBoost maintained good predictive performance in the external validation cohort (area under the curve 0.86; average precision 0.71; F1-score=0.68). Baseline DM was identified as the CKM risk factor with the highest feature importance for MACEs, with SHAP values of 0.17 in female patients and 0.23 in male patients. Conversely, CKD emerged as the most important CKM risk factor in female patients (SHAP value 0.18), while DM ranked highest in male participants. Conclusions: This study confirmed that CKM risk factors and their influence on prognosis in patients with MSCAC exhibit significant sex differences. The application of machine learning, particularly XGBoost, facilitates a deeper understanding of these disparities and provides a basis for personalized, sex-specific risk assessment and targeted interventions for patients with MSCAC.

24 June 2021 in Surgical Endoscopy
Verified
Journal Article
Open access
PDF file
JZJian Zhou
Jian Zhou
HLHu Liao
Hu Liao
ZLZhangyu Lin
Zhangyu Lin
MLMengyuan Lyu
Mengyuan Lyu
WCWeelic Chong
Weelic Chong
LLLunxu Liu
Lunxu Liu
Purpose We report a new thoracoscopic surgical skill training and assessment system with automatic scoring techniques, the Huaxi Intelligent Thoracoscopic Skill Training and Assessment (HITSTA) system. We also evaluated the discriminative ability of this system compared to our conventional scoring method at our institution. Methods We retrospectively collected training data of thoracic board-certified thoracic surgeons at West China Hospital, Sichuan University from January 1, 2018 to January 1, 2019. Surgeons were assessed by HITSTA system and human examiners simultaneously. Total scores were summed from 3 tasks (grasping with delivery, pattern cutting, and suture with knot). Bland–Altman analysis was used to test agreement of scores made by HITSTA system (automatic scoring) and human examiners (manual scoring). Differentiation ability was also compared between the two scoring methods. Results Thirty-nine surgeons were recruited. Scores made by HITSTA system and human examiners were not consistent. For suture with knot, automatic scoring method could detect the score differences between different training status (trained: 26.92 ± 12.04, untrained: 19.85 ± 11.12; p = 0.026) and training duration (< 10 h: 20.67 ± 15.23, ≥ 10 h: 31.92 ± 5.56; p = 0.003). For total scores, automatic scoring approach could discriminate between different training status (trained: 71.90 ± 12.63; untrained: 61.41 ± 13.87; p = 0.016) and training duration (< 10 h: 65.23 ± 15.31; ≥ 10 h 77.23 ± 6.94; p = 0.046). Conclusion HITSTA system could discriminate the different levels of thoracoscopic surgical skills better than the traditional manual scoring method. Larger prospective studies are warranted to validate the differentiation ability of HITSTA system.

11 July 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
ZYZixiang Ye
Zixiang Ye
ZLZhangyu Lin
Zhangyu Lin
EXEnmin Xie
Enmin Xie
CSChenxi Song
Chenxi Song
RZRui Zhang
Rui Zhang
KDKefei Duo
Kefei Duo
Background: Given the challenges faced during percutaneous coronary intervention (PCI) for heavily calcified lesions, accurately predicting PCI success is crucial for enhancing patient outcomes and optimizing procedural strategies. Objective: This study aimed to use machine learning (ML) to identify coronary angiographic vascular characteristics and PCI procedures associated with the immediate procedural success rates of PCI in patients exhibiting moderate to severe coronary artery calcification (MSCAC). Methods: This study included patients who underwent PCI between January 2017 and December 2018 in a cardiovascular hospital, comprising 3271 patients with MSCAC and 17,998 with no or mild coronary artery calcification. Six ML models—k-nearest neighbor, gradient boosting decision tree, Extreme Gradient Boosting (XGBoost), logistic regression, random forest, and support vector machine—were developed and validated, with synthetic minority oversampling technique used to address imbalance data. Model performance was compared using multiple parameters, and the optimal algorithm was selected. Model interpretability was facilitated by Shapley Additive Explanations (SHAP), identifying the top 6 coronary angiographic features with the highest SHAP values. The importance of different PCI procedures was also elucidated via SHAP values. Testing validation was performed in a separate cohort of 1437 patients with MSCAC in 2013. External validation was conducted in a general hospital of 204 patients with MSCAC in 2021. Sensitivity analyses were conducted in patients with acute coronary syndrome and chronic coronary syndrome. Results: In the development cohort, 7.6% (n=248) of patients with MSCAC experienced PCI failure compared to 4.3% (n=774) of patients with no or mild coronary artery calcification. The XGBoost model demonstrated superior performance, achieving the highest area under the receiver operator characteristic curve (AUC) of 0.984, average precision (AP) of 0.986, F1-score of 0.970, and G-mean of 0.970. Calibration curves indicated reliable predictive accuracy. The key predictive factors identified included lesion length, minimum lumen diameter, thrombolysis in myocardial infarction flow grade, chronic total occlusion, reference vessel diameter, and diffuse lesion (SHAP value 1.65, 1.40, 0.92, 0.60, 0.54, and 0.47, respectively). The use of modified balloons for calcified lesions had a positive effect on PCI success in patients with MSCAC (SHAP value 0.16). Sensitivity analyses showed consistent model performance across subgroups with similar top 5 coronary angiographic variables. The optimized XGBoost model maintained robust predictive performance in the testing cohort, with an AUC of 0.972, AP of 0.962, and F1-score of 0.940, and in the external validation set, with an AUC of 0.810, AP of 0.957, and F1-score of 0.892. Conclusions: This study successfully revealed the important PCI failure risk factors, such as lesion length and modified balloons, using ML models to help clinicians manage PCI strategies in patients with complex coronary artery disease such as MSCAC.

9 December 2020 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
PDF file
YCYuhui Cheng
Yuhui Cheng
LJLin Jiao
Lin Jiao
WLWeixiu Li
Weixiu Li
JWJialing Wang
Jialing Wang
ZLZhangyu Lin
Zhangyu Lin
BYBinwu Ying
Binwu Ying
Background: The role of collagen type XVIII alpha 1 chain ( COL18A1 ) in anti‐tuberculosis drug‐induced hepatotoxicity (ATDH) has not been reported. This study aimed to explore the association between of COL18A1 variants and ATDH susceptibility. Methods: A total of 746 patients were enrolled in our study from December 2016 to April 2018, and all subjects in the study signed an informed consent form. The custom‐by‐design 2x48‐Plex SNPscanTM kit was used to genotype all selected 11 SNPs. Categorical variables were compared by chi‐square (χ 2 ) or Fisher's exact test, while continuous variables were compared by Mann‐Whitney's U test. Plink was utilized to analyze allelic and genotypic frequencies, and genetic models. Multivariate logistic regression analyses were used to adjust potential factors. The odds ratios (ORs) with corresponding 95% confidence intervals (CIs) were also calculated. Results: Among patients with successfully genotyping, there were 114 cases and 612 controls. The mutant A allele of rs12483377 conferred the decreased risk of ATDH (OR = 0.13, 95%CI: 0.02–0.98, P = 0.020), and this significance still existed after adjusting age and gender ( P = 0.024). The mutant homozygote AA genotype of rs12483377 was associated with decreased total protein levels ( P = 0.018). Conclusion: Our study first revealed that the A allele of COL18A1 rs12483377 was associated with the decreased risk of ATDH in the Western Chinese Han population, providing new perspective for the molecular prediction, precise diagnosis, and individual treatment of ATDH.

6 January 2026 in Journal of the American Heart Association
Verified
Journal Article
Open access
YDYuan Du
Yuan Du
SHSen Han
Sen Han
JCJiaxi Cheng
Jiaxi Cheng
ZLZhangyu Lin
Zhangyu Lin
YSYanjun Song
Yanjun Song
KDKe-Fei Dou
Ke-Fei Dou
Background: Previous studies have identified a link between cancer and cardiovascular disease; however, the underlying genetic and proteomic mechanisms remain unclear. Therefore, this study aimed to investigate the association between cancer diagnosis and cardiovascular mortality and to explore the potential mechanisms involved. Methods: A total of 379 944 participants without cardiovascular disease at baseline, including 65 047 individuals with cancer, were recruited from the UK Biobank database. The primary end point was cardiovascular death. Multivariate Cox regression was performed to evaluate the risk of cardiovascular death in populations with and without cancer. Genome‐wide association studies, phenome‐wide association studies, and proteomic analyses were applied to investigate the underlying genetic and proteomic mechanisms. Results: Multivariate Cox regression analysis showed an increased risk of cardiovascular death in the group with cancer (hazard ratio, 1.50 [95% CI, 1.40–1.61]) after multivariable adjustment. Proteomic analysis confirmed a strong association between cancer and cardiovascular disease, primarily involving pathways related to complement and coagulation cascades, and various inflammatory processes. In contrast, genome‐wide association studies and phenome‐wide association studies revealed only a limited number of shared genetic variations between cancer and cardiovascular conditions, such as hypertension and cardiac dysrhythmias. Conclusions: Cardiovascular risk is increased in patients with cancer and may be related to altered expression of inflammation‐ and coagulation‐related proteins. In clinical practice, it is recommended to emphasize the management of endocrine, kidney, and inflammation‐related risk factors in the population with cancer.